4//SEC Filing
KIRSKE DAVID 4
Accession 0001276750-25-000004
CIK 0001501697other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:41 PM ET
Size
5.8 KB
Accession
0001276750-25-000004
Insider Transaction Report
Form 4
KIRSKE DAVID
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-10-29+1,552,769→ 1,552,769 totalExercise: $1.42Exp: 2035-08-12→ Common Stock (1,552,769 underlying)
Footnotes (1)
- [F1]Represents stock options granted to the Reporting Person on August 12, 2025, which were subject to a performance-based vesting condition that was satisfied on October 29, 2025. One third of the shares subject to the option shall vest on August 12, 2026, with the remainder vesting in equal installments each successive month thereafter for a period of 24 months, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001276750
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:41 PM ET
- Size
- 5.8 KB